iodamide has been researched along with Prostatic Hyperplasia in 1 studies
Iodamide: An ionic monomeric contrast medium. (From Martindale, The Extra Pharmacopoeia, 30th ed, p706)
iodamide : A benzoic acid compound having iodo substituents at the 2-, 4- and 6-positions, an acetamido substituent at the 3-position and an acetamidomethyl substituent at the 5-position.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grasso, N | 1 |
1 other study available for iodamide and Prostatic Hyperplasia
| Article | Year |
|---|---|
[On some cystographic appearances of prostatic pathology (author's transl)].
Topics: Chronic Disease; Humans; Iodamide; Male; Prostatic Diseases; Prostatic Hyperplasia; Prostatitis; Rad | 1981 |